Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer.
The four antiandrogens currently available (cyproterone acetate, flutamide, nilutamide and bilcalutamide) are reviewed relative to their structure, pharmacology and clinical effect.
Department of Surgery, University of Toronto, Sunnybrook Health Science Centre, Toronto, Ontario.
John
J
Trachtenberg
Hesam
H
Farival-Mohseni
Michael A.S.
MA
Jewett